128 results on '"Prabhakaran, Sarita"'
Search Results
2. Molecular Characterization of Testicular Mesothelioma and the Role of Asbestos as a Causative Factor
3. The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature
4. Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer
5. Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression
6. Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational study
7. Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread
8. Altered endosomal-lysosomal biogenesis in melanoma
9. Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers
10. Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer
11. Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer
12. Solitary calcifying fibrous tumour of the pleura: A case report and literature review
13. Insights into Melanoma Clinical Practice: A Perspective for Future Research
14. Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data
15. Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1
16. The Incidence of Labelling of Non–Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications
17. Dynamic interplay between sortilin and syndecan-1 drives a metabolic switch during prostate cancer progression
18. Pulmonary artery intimal sarcoma presenting as lung mass
19. Contribution of the pathologist to mesothelioma diagnosis
20. Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers
21. The long‐term mortality of an Aboriginal and Torres Strait Islander Australian population after isolated coronary artery bypass graft surgery
22. Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer
23. Bortezomib Stabilizes Mitotic Cyclins and Prevents Cell Cycle Progression via Inhibition of UBE2C in Colorectal Carcinoma
24. Molecular markers and pathway analysis of colorectal carcinoma in the Middle East
25. Progression of Well-Differentiated Papillary Mesothelial Tumour to Mesothelioma in a Patient with Ehlers Danlos Syndrome
26. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer
27. Prognostic Significance of JMJD3 Expression in Pleural Mesotheliomas
28. Progression of Well-Differentiated Papillary Mesothelial Tumour to Mesothelioma in a Patient with Ehlers Danlos Syndrome
29. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas
30. A comparison of diagnostic panels in the immunohistochemical analysis of lung cancer
31. Prostate cancer biomarker atlas
32. The Incidence of Labelling of Non–Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications
33. Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
34. Microvascular density or nuclear grade for mesothelioma: one method to fit them all?
35. The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma
36. The role of HER2 overexpression in Middle Eastern papillary thyroid cancer
37. Additional file 1: Table S1. of ALK alteration is a frequent event in aggressive breast cancers
38. ALK alteration is a frequent event in aggressive breast cancers
39. Abstract 4323: ALK overexpression is associated with activation of PI3K/AKT signaling pathway in PTC
40. Abstract 3945: PTEN loss is associated with aggressive behavior and poor prognosis in Middle Eastern Triple Negative Breast Cancer
41. Abstract 2727: Molecular markers and pathway analysis of Middle Eastern colorectal carcinoma
42. A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma
43. Abstract 1213: Clinicopathological significance of ALK alterations in colorectal carcinoma.
44. Abstract 2104: Frequent inactivation of A20 and its prognostic significance in Middle Eastern colorectal carcinoma
45. Abstract 4412: Prognostic significance of NF-κB in Middle Eastern diffuse large B cell lymphoma and efficacy of NF-κB inhibition as a viable therapeutic target
46. Abstract 2980: Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target
47. Abstract 1069: Clinicopathological significance of CARD10 alterations in Middle Eastern colorectal cancer
48. Abstract 2711: JC virus T-Antigen (SV40) is an independent prognostic marker for poor disease free survival in epithelial ovarian carcinoma
49. Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
50. Prognostic significance of TRAIL death receptorsin Middle Eastern colorectal carcinomas and theircorrelation to oncogenic KRAS alterations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.